Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycogen phosphorylase inhibitors.

Brad R Henke1, Steven M Sparks

  • 1Metabolic and Viral Diseases Drug Discovery, GlaxoSmithKline, P.O. Box 13398, Research Triangle Park, NC 27705, USA. Brad.R.Henke@gsk.com

Mini Reviews in Medicinal Chemistry
|August 22, 2006
PubMed
Summary

Small molecule inhibitors targeting glycogen phosphorylase, an enzyme crucial for glucose release, show promise for treating Type 2 diabetes by lowering high blood sugar levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk.

PloS one·2023
Same author

Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.

Journal of medicinal chemistry·2021
Same author

Inhibitor Mimetic Mutations in the <i>Pseudomonas aeruginosa</i> PqsE Enzyme Reveal a Protein-Protein Interaction with the Quorum-Sensing Receptor RhlR That Is Vital for Virulence Factor Production.

ACS chemical biology·2021
Same author

A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.

Molecular genetics and metabolism·2021
Same author

Mechanism underlying autoinducer recognition in the <i>Vibrio cholerae</i> DPO-VqmA quorum-sensing pathway.

The Journal of biological chemistry·2020
Same author

Discovery of PqsE Thioesterase Inhibitors for <i>Pseudomonas aeruginosa</i> Using DNA-Encoded Small Molecule Library Screening.

ACS chemical biology·2019

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • Type 2 diabetes is characterized by hyperglycemia.
  • Elevated hepatic glucose output contributes to hyperglycemia in Type 2 diabetes.
  • Glycogenolysis, catalyzed by glycogen phosphorylase, is a key process in hepatic glucose production.

Purpose of the Study:

  • To review advances in small molecule inhibitors of glycogen phosphorylase.
  • To discuss the biological activity of these inhibitors.
  • To evaluate their potential as antihyperglycemic agents for Type 2 diabetes.

Main Methods:

  • Literature review of small molecule inhibitors of glycogen phosphorylase.
  • Analysis of their biological activity and antihyperglycemic effects.

Main Results:

  • Small molecule inhibitors of glycogen phosphorylase have been designed.
  • These inhibitors demonstrate biological activity relevant to glucose metabolism.
  • Evidence suggests their potential efficacy in managing hyperglycemia.

Conclusions:

  • Inhibiting glycogen phosphorylase is a viable strategy for reducing hepatic glucose output.
  • Small molecule inhibitors of glycogen phosphorylase represent a promising therapeutic approach for Type 2 diabetes.
  • Further development of these agents could lead to effective antihyperglycemic treatments.

Related Experiment Videos